Hormonal determinants and disorders of peak bone mass in children

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 3951-3963

  Soyka, L A ^a   Fairfield, W P ^a   Klibanski, A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE; HORMONE;

BONE DENSITY; BONE MASS; CHILD; COMORBIDITY; ENDOCRINE DISEASE; GROWTH HORMONE DEFICIENCY; HEREDITY; HORMONAL REGULATION; HUMAN; HYPOGONADISM; KLINEFELTER SYNDROME; NUTRITION; PRIORITY JOURNAL; REVIEW; TURNER SYNDROME; ADOLESCENT; ADULT; BONE DISEASE; FEMALE; GROWTH DISORDER; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; BONE DENSITY; BONE DISEASES; CHILD; FEMALE; GROWTH DISORDERS; HORMONES; HUMANS; KLINEFELTER SYNDROME; MALE; MIDDLE AGED; TURNER SYNDROME;

EID: 0034527548     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.11.3951     Document Type: Review

References (140)

1. Timing of peak bone mass in caucasian females and its implication for the prevention of osteoporosis
2. Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: Correlations with growth parameters
3. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty
4. Longitudinal monitoring of bone mass accumulation in healthy adolescent girls: Evidence for marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
5. The differing tempo of growth in bone size, mass, and density in girls is region-specific
6. Bone mineral status in childhood accidental fractures
7. Heritable and lifestyle determinants of bone mineral density
8. Reduced bone mass in daughters of women with osteoporosis
9. Heritability of bone mass: A longitudinal study in aging male twins
10. Prediction of bone density from vitamin D receptor alleles
11. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
12. Vitamin D receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent
13. The Bsm1 receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density
14. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype
15. Do dietary calcium and age explain the controvery surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?
16. Association of collagen type 1 α1 gene polymorphism with bone density in early childhood
17. Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: A cross-sectional and longitudinal study
18. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women
19. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism
20. Osteopenia in men with a history of delayed puberty
21. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty
22. The localization of androgen receptors in human bone
23. Influences on skeletal mineralization in children and adolescents: Evidence for varying effects of sexual maturation and physical activity
24. The role of estrogen in pubertal skeletal physiology: Epiphyseal maturation and mineralization of the skeleton
25. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
26. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
27. Effect of Testosterone and Estradiol in a man with aromatase deficiency
28. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
29. Scoliosis and fractures in young ballet dancers
30. Bone Mineral Density in 15-21 year old Eumenorrheic and amenorrheic subjects
31. Lack of bone accretion and amenorrhea: Evidence for a relative osteopenia in weight-bearing bones
32. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults
33. Recovery from osteopenia in adolescent girls with anorexia nervosa
34. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa
35. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication
36. Insulin-like growth factors and skeletal growth: Possibilities for therapeutic interventions
37. Insulin-like growth factors in pediatric health and disease
38. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency
39. Growth hormone deficiency during puberty reduces adult bone mineral density
40. Influence of body composition on bone mineral content in children and adolescents
41. Decreased bone density in adolescent girls with anorexia nervosa
42. The effects of anorexia nervosa on bone metabolism in female adolescents
43. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa
44. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents
45. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls
46. Bone mineral and calcium accretion during puberty
47. Calcium supplementation and increases in bone mineral density in children
48. Calcium supplementation and bone mineral density in adolescent girls
49. Exercise before puberty may confer residual benefits in bone density in adulthood: Studies in active prepubertal and retired female gymnasts
50. Delayed menarche and amenorrhea of college athletes in relation to age and onset of training
51. Turner syndrome and osteoporosis: Mechanisms and prognosis
52. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome
53. Turner syndrome adolescents receiving growth hormone are not osteopenic
54. Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome
55. Turner syndrome: Final height, glucose tolerance, bone density and psychosocial status in 25 adult patients
56. Osteoporosis in Turner's syndrome and other forms of primary amenorrhea
57. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome
58. Growth and body proportions in 54 boys and men with Klinefelter's syndrome
59. Osteoporosis and Klinefelter's syndrome
60. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism
61. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months
62. Comment on normal volumetric bone mineral density and bone tunover in young men with histories of constitutional delay of puberty
63. Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset
64. Consequences of childhood-onset growth hormone deficiency for adult bone mass
65. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency
66. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency
67. Effect of growth hormone therapy on bone metabolism of growth hormone deficient children
68. Changes in bone mineral density, body composition and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency
69. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency, role of GH in the attainment of peak bone mass
70. Growth hormone and the maintenance of adult bone density
71. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency
72. Pituitary macroadenoma and Cushing's disease in pediatric patients: Patient report and review of the literature
73. Cushing's syndrome in children and adolescents
74. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease
75. The effect of Cushing's disease on bone mineral density, body composition, growth and puberty: A report of an identical adolescent twin pair
76. Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment
77. Bone loss and bone turnover in diabetes
78. Bone mineral density and bone metabolism in diabetes mellitus
79. A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus
80. Diabetes mellitus and risk of skeletal fracture
81. Calcaneal fractures in diabetic patients
82. Prospective bone mineral density evaluation in patients with insulin-dependent diabetes mellitus
83. Bone mineral density of the lumbar vertebrae in children and adolescents with insulin-dependent diabetes mellitus
84. Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset
85. Lumbar spine bone mineral density in diabetic children with recent onset
86. Vertebral bone density in insulin-dependent diabetic children
87. Bone mineral density in children and adolescents with juvenile diabetes: Selective measurement of bone mineral density of trabecular and cortical bone using peripheral quantitative computed tomography
88. Glucocorticoid effects on statural growth
89. Glucocorticoid-induced osteoporosis: Pathogenesis and management
90. Steroid-induced fractures and bone loss in patients with asthma
91. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment
92. Bone mineral in lumbar spine, femoral neck and femoral shaft measured by dual photon absorptiometry with 153-gadolineum in prednisone treatment
93. Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells
94. Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro
95. Bone formation in hypercortisonism
96. Glucocorticoids and bone resorption
97. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose
98. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration
99. 3 in children receiving glucocorticoids
100. Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man
101. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects
102. Cortisol-induced suppression of plasma testosterone in normal adult males
103. Effect of glucocorticoids on plasma testosterone in men
104. Night and day growth hormone levels during treatment with corticosteroids and corticotrophin
105. Glucocorticoid effects on somatomedins and somatomedin inhibitors
106. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy
107. Evolution of osteopenia in inflammatory bowel disease
108. Bone mineral metabolism in pediatric inflammatory bowel disease
109. Risk factors for low bone mineral density in children and young adults with Crohn's disease
110. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
111. Metabolic bone assessment in patients with inflammatory bowel disease
112. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease
113. Bone mineral density assessment in children with inflammatory bowel disease
114. Osteoporosis in patients with inflammatory bowel disease
115. Bone loss in patients with inflammatory bowel disease is less than expected: A follow-up study
116. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
117. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
118. Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling
119. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines
120. Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease
121. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: A 1 year prospective study
122. Relative osteopenia after treatment for acute lymphoblastic leukemia
123. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy
124. Osteopenia in children surviving brain tumors
125. Increased rate of fractures and severe kyphosis: Sequelae of living into adulthood with cystic fibrosis
126. Bone demineralization in cystic fibrosis: Evidence of imbalance between bone formation and degradation
127. Bone density in children and adolescents with cystic fibrosis
128. Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study
129. Bone mineral density and body composition in adult patients with cystic fibrosis
130. Osteoporosis in cystic fibrosis
131. Correlates of osteopenia in patients with cystic fibrosis
132. Low bone mineral density in adults with cystic fibrosis
133. Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis
134. Correspondence
135. Estimation of bone mineral density in children with juvenile rheumatoid arthritis
136. 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: Short-term effects on serum osteocalcin levels and bone mineral density
137. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis
138. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis
139. Bone rarefaction and crush fractures in juvenile chronic arthritis
140. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases